|
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
Clinical Trial Cardio IQ Vitamin D 25 LC/MS/MS
Test CodeCPT Codes
82306<br>Restricted Client Code
Preferred Specimen
Patient Preparation
Fasting preferred, but not required.
Minimum Volume
Instructions
Collect blood in a standard red-top serum vacutainer tube. Allow blood to clot at room temperature. Centrifuge and separate the serum from the cells immediately.
Alternatively, collect blood in a serum separator tube, allow to clot at room temperature, centrifuge and remove from the gel within 48 hours.
Transport Temperature
Specimen Stability
Refrigerated: 21 days
Frozen -20° C: 21 days
Frozen -70° C: 18 months
Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Methodology
Liquid Chromatography/Tandem Mass Spectrometry
FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.
Setup Schedule
Reference Range
Vitamin D, 25-OH, Total: 30-100 ng/mL
Vitamin D, 25-OH, D3: Not established
Vitamin D, 25-OH, D2: Not established
For more information on this test, go to http://education.questdiagnostics.com/faq/25-OHVitaminD
Clinical Significance
Measurement of serum 25-OH vitamin D concentrations provide a good index of circulating vitamin D activity in patients not suffering from renal disease. Lower than normal 25-OH vitamin D levels can result from a dietary deficiency, poor abosrption of the vitamin or impaired metabolism of the sterol in the liver. A 25-OH vitamin D deficiency can lead to bone diseases such as rickets and osteomalacia. Above normal levels can lead hypercalcemia.
This assay employs liquid chromatography tandem mass spectrometry to independently measure and report the two common forms of 25-hydroxy vitamin D: 25OH D 3 - the endogenous form of the vitamin and 25OH D 2 - the analog form used to treat 25OH Vitamin D 3 deficiency.